Metabolic dysfunction-associated steatohepatitis (MASH) and atherosclerosis are cardiometabolic twin disorders with shared underlying pathophysiological mechanisms such as insulin resistance and chronic inflammation. This review explores the salient role of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in linking hepatic dysfunction to cardiovascular disease. Findings in mice with genetic modulation of Ceacam1 gene established a critical role for CEACAM1 protein in regulating insulin and lipid metabolism and endothelial integrity and modulating immune response. Loss of CEACAM1 in hepatocytes impairs insulin clearance, causing chronic hyperinsulinemia, a process that ultimately leads to insulin resistance and hepatic and extra-hepatic fat accumulation, which in turn causes inflammatory infiltration. This prompts a paradigm shift that positions impaired hepatic CEACAM1 function as a mechanistic underpinning of the link between insulin resistance, MASH, and atherosclerosis.
8 June 2026 in European Journal of Case Reports in Internal Medicine
Melanosis ilei is an uncommon, benign condition characterized by dark pigmentation of the terminal ileal mucosa. Usually asymptomatic, it is frequently found incidentally during endoscopic examination. We report a 42-year-old female with iron deficiency anaemia receiving oral iron treatment who had a colonoscopy and gastroscopy as part of anaemia workup. The results of the colonoscopy and gastroscopy were uneventful, but deep intubation of the terminal ileum showed many distinct to confluent dark brown pigmented areas that seemed peppered and speckled. Melanosis ilei was confirmed by the histopathology of ileal samples, which showed pigment-laden macrophages in the lamina propria. This etiology was attributed to long-term iron supplementation. Recognition of the characteristic endoscopic and histopathologic features of melanosis ilei is important to prevent misdiagnosis and unnecessary interventions.
12 May 2026 in Clinical Medicine Insights: Case Reports
Background: Hereditary pancreatitis is a rare type of chronic pancreatitis that is due to an inherited germline mutation, involving pancreatic trypsin activity. This condition causes either increased trypsinogen activation or impaired trypsin inhibition/degradation, resulting in recurrent pancreatic injury and progression to chronic pancreatitis. Case presentation: We present the case of a young male who presented with acute pancreatitis in the setting of a positive family history of chronic pancreatitis. He had no prior similar episodes. Imaging revealed features consistent with chronic calcific pancreatitis, including diffuse dilation of the main pancreatic duct with intraductal stones. The patient underwent ERCP with pancreatic sphincterotomy and successful removal of multiple pancreatic stones resulting in symptomatic relief. Genetic testing confirmed the diagnosis of hereditary pancreatitis with identification of a pathogenic PRSS1 mutation. Management: Therapeutic interventions typically involve management of acute pancreatitis flares and its complications, chronic pain management, exocrine and endocrine insufficiency, and endoscopic and surgical interventions, and genetic counseling and surveillance. Conclusion: Our case report emphasizes the significance of taking hereditary pancreatitis into account in acute-on-chronic presentations. This helps in establishing a genetic diagnosis for directing treatment, long-term surveillance, and family screening.